Financials (USD)
Sales 2024 * | 25.16M | Sales 2025 * | 81.93M | Capitalization | 295M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | 6M | EV / Sales 2024 * | 11.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.6 x |
P/E ratio 2024 * |
-7.28
x | P/E ratio 2025 * |
-230
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.99% |
Latest transcript on CorMedix Inc.
Managers | Title | Age | Since |
---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 48 | 22-03-17 |
Mathew David
DFI | Director of Finance/CFO | 47 | 20-05-10 |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Myron Kaplan
CHM | Chairman | 79 | 16-04-26 |
Steven Lefkowitz
DFI | Director of Finance/CFO | 68 | 11-08-14 |
Alan Dunton
BRD | Director/Board Member | 70 | 19-02-28 |
1st Jan change | Capi. | |
---|---|---|
+4.30% | 69.17B | |
+12.55% | 9.06B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+21.52% | 2.41B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |